成年小鼠中肥胖诱导的心脏脂质积累受G蛋白偶联受体激酶2水平调节。

Obesity-induced cardiac lipid accumulation in adult mice is modulated by G protein-coupled receptor kinase 2 levels.

作者信息

Lucas Elisa, Vila-Bedmar Rocio, Arcones Alba C, Cruces-Sande Marta, Cachofeiro Victoria, Mayor Federico, Murga Cristina

机构信息

Departamento de Biología Molecular and Centro de Biología Molecular Severo Ochoa (UAM-CSIC), C/Nicolas Cabrera 1, 28049, Madrid, Spain.

Instituto de Investigación Sanitaria La Princesa, Madrid, Spain.

出版信息

Cardiovasc Diabetol. 2016 Nov 10;15(1):155. doi: 10.1186/s12933-016-0474-6.

Abstract

BACKGROUND

The leading cause of death among the obese population is heart failure and stroke prompted by structural and functional changes in the heart. The molecular mechanisms that underlie obesity-related cardiac remodeling are complex, and include hemodynamic and metabolic alterations that ultimately affect the functionality of the myocardium. G protein-coupled receptor kinase 2 (GRK2) is an ubiquitous kinase able to desensitize the active form of several G protein-coupled receptors (GPCR) and is known to play an important role in cardiac GPCR modulation. GRK2 has also been recently identified as a negative modulator of insulin signaling and systemic insulin resistance.

METHODS

We investigated the effects elicited by GRK2 downregulation in obesity-related cardiac remodeling. For this aim, we used  9 month-old wild type (WT) and GRK2+/- mice, which display circa 50% lower levels of this kinase, fed with either a standard or a high fat diet (HFD) for 30 weeks. In these mice we studied different parameters related to cardiac growth and lipid accumulation.

RESULTS

We find that GRK2+/- mice are protected from obesity-promoted cardiac and cardiomyocyte hypertrophy and fibrosis. Moreover, the marked intracellular lipid accumulation caused by a HFD in the heart is not observed in these mice. Interestingly, HFD significantly increases cardiac GRK2 levels in WT but not in GRK2+/- mice, suggesting that the beneficial phenotype observed in hemizygous animals correlates with the maintenance of GRK2 levels below a pathological threshold. Low GRK2 protein levels are able to keep the PKA/CREB pathway active and to prevent HFD-induced downregulation of key fatty acid metabolism modulators such as Peroxisome proliferator-activated receptor gamma co-activators (PGC1), thus preserving the expression of cardioprotective proteins such as mitochondrial fusion markers mitofusin MFN1 and OPA1.

CONCLUSIONS

Our data further define the cellular processes and molecular mechanisms by which GRK2 down-regulation is cardioprotective during diet-induced obesity, reinforcing the protective effect of maintaining low levels of GRK2 under nutritional stress, and showing a role for this kinase in obesity-induced cardiac remodeling and steatosis.

摘要

背景

肥胖人群的主要死因是心力衰竭和由心脏结构与功能变化引发的中风。肥胖相关心脏重塑的分子机制十分复杂,包括血流动力学和代谢改变,这些改变最终会影响心肌功能。G蛋白偶联受体激酶2(GRK2)是一种普遍存在的激酶,能够使几种G蛋白偶联受体(GPCR)的活性形式脱敏,并且已知在心脏GPCR调节中发挥重要作用。GRK2最近还被鉴定为胰岛素信号传导和全身胰岛素抵抗的负调节剂。

方法

我们研究了GRK2下调对肥胖相关心脏重塑的影响。为此,我们使用了9个月大的野生型(WT)和GRK2+/-小鼠,这些小鼠的这种激酶水平大约低50%,分别用标准饮食或高脂饮食(HFD)喂养30周。在这些小鼠中,我们研究了与心脏生长和脂质积累相关的不同参数。

结果

我们发现GRK2+/-小鼠可免受肥胖引发的心脏和心肌细胞肥大及纤维化的影响。此外,这些小鼠未观察到由HFD导致的心脏内明显的细胞内脂质积累。有趣的是,HFD显著增加了WT小鼠的心脏GRK2水平,但在GRK2+/-小鼠中未增加,这表明在半合子动物中观察到的有益表型与将GRK2水平维持在病理阈值以下有关。低GRK2蛋白水平能够保持PKA/CREB途径的活性,并防止HFD诱导的关键脂肪酸代谢调节剂如过氧化物酶体增殖物激活受体γ共激活因子(PGC1)的下调,从而保留心脏保护蛋白如线粒体融合标记物线粒体融合蛋白MFN1和OPA1的表达。

结论

我们的数据进一步明确了GRK2下调在饮食诱导的肥胖期间具有心脏保护作用的细胞过程和分子机制,加强了在营养应激下维持低水平GRK2的保护作用,并表明该激酶在肥胖诱导的心脏重塑和脂肪变性中发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a11/5105284/ada80357f0fc/12933_2016_474_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索